🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/08/2010 12,48 12,54 12,12 12,12 -2,42% 3,37% 166.833
17/08/2010 12,06 12,48 11,94 12,42 +3,50% 4,48% 203.683
16/08/2010 11,46 12,18 11,16 12,00 +4,71% 8,90% 188.283
13/08/2010 11,82 11,88 11,46 11,46 -3,54% 3,55% 148.367
12/08/2010 11,76 12,30 11,64 11,88 -0,50% 5,61% 186.067
11/08/2010 12,00 12,78 11,76 11,94 -1,97% 8,50% 415.050
10/08/2010 11,46 12,54 11,34 12,18 +2,01% 10,47% 490.367
09/08/2010 11,94 12,00 11,58 11,94 +1,02% 3,52% 163.633
06/08/2010 11,70 11,88 11,46 11,82 +1,03% 3,59% 226.400
05/08/2010 11,82 11,82 11,58 11,70 -1,52% 2,03% 52.417
04/08/2010 11,70 11,88 11,46 11,88 +2,59% 3,59% 210.000
03/08/2010 11,76 11,88 11,40 11,58 -2,53% 4,08% 225.033
02/08/2010 11,82 12,06 11,64 11,88 +1,54% 3,55% 308.783
30/07/2010 11,16 11,82 11,10 11,70 +3,72% 6,45% 325.217
29/07/2010 11,46 11,58 11,16 11,28 -1,05% 3,66% 141.783
28/07/2010 11,40 11,46 10,80 11,40 +2,70% 5,79% 283.000
27/07/2010 11,70 11,70 10,92 11,10 -3,14% 6,67% 297.767
26/07/2010 11,34 11,70 10,98 11,46 +6,11% 6,35% 435.033
23/07/2010 10,74 10,86 10,38 10,80 +0,56% 4,47% 259.533
22/07/2010 11,04 11,04 10,62 10,74 -1,10% 3,80% 310.233
21/07/2010 11,64 11,94 10,68 10,86 -1,63% 10,82% 559.633
20/07/2010 11,58 11,58 10,80 11,04 -5,15% 6,74% 574.817
19/07/2010 10,98 11,76 10,56 11,64 +7,18% 10,93% 729.217
16/07/2010 11,70 12,42 10,80 10,86 +11,04% 13,85% 1.208.350
15/07/2010 9,96 10,26 9,72 9,78 -1,81% 5,42% 364.850
14/07/2010 9,54 10,08 9,48 9,96 +3,11% 6,29% 223.567
13/07/2010 9,54 9,66 9,30 9,66 +3,21% 3,77% 134.700
12/07/2010 9,84 9,90 9,30 9,36 -4,88% 6,10% 160.850
09/07/2010 9,42 9,96 9,24 9,84 +4,46% 7,64% 179.283
08/07/2010 9,18 9,48 8,88 9,42 +6,80% 6,54% 268.217